Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▴
AUPH	Aurinia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$287.20M	n/a	49.4%	n/a	$2.07
NCEL	NewcelX Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.30M	n/a	-114.5%	n/a	$2.16
ACAD	Acadia Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$1.07B	$391.00M	36.5%	31.9%	11.9%	$2.30
KROS	Keros Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$244.06M	$87.01M	35.7%	28.7%	n/m	$2.30
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
EOCN	Galmed Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$6.90M	n/a	43.7%	n/a	$2.39
QTTB	Q32 Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.74M	$29.82M	55.5%	71.0%	n/a	$2.42
PAHC	Phibro Animal Health Corp Manufacturing · Year ended 2026-06-30 · USD	$1.52B	$99.72M	6.6%	25.9%	17.1%	$2.43
HRMY	Harmony Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$868.45M	$158.69M	18.3%	18.2%	21.5%	$2.71
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
INVA	Innoviva, Inc. Manufacturing · Year ended 2025-12-31 · USD	$411.33M	$271.17M	65.9%	23.1%	14.7%	$3.30
ANIP	ANI Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$883.37M	$78.34M	8.9%	14.5%	43.8%	$3.32
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
ABT	Abbott Laboratories Manufacturing · Year ended 2025-12-31 · USD	$44.33B	$6.52B	14.7%	12.5%	5.7%	$3.72
PBH	Prestige Consumer Healthcare Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.09B	$190.30M	17.5%	10.1%	-4.3%	$3.91
DMRA	Damora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$209.84M	n/a	-87.3%	n/a	$3.98
ZTS	Zoetis Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.47B	$2.67B	28.2%	80.2%	2.3%	$6.02
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
MRK	Merck & Co., Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.01B	$18.25B	28.1%	34.7%	1.3%	$7.28
PTCT	PTC Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.73B	$682.64M	39.4%	n/a	114.5%	$7.78
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
VRTX	Vertex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$12.00B	$3.95B	32.9%	21.2%	8.9%	$15.32
RIGL	Rigel Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	$367.02M	n/a	93.8%	n/a	$19.48
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95

Rows per page: 2550 100